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Introduction
In this issue of the PCRJ, Bishara et al.1 present a case report about
the treatment of a pregnant woman with tuberculosis (TB). She had
emigrated from a country with a high prevalence of TB to one with
a lower prevalence. This presented a challenge to her physicians who
were faced with identifying and treating close contacts who were
also infected. This Perspective article explores in more depth some of
the questions raised by this case report. It discusses the role of
primary care physicians in low prevalence countries who can
implement evidence-based screening programmes, it discusses
effective strategies for the diagnosis and treatment of TB in countries
with high TB prevalence, and it presents insights from medical
anthropology that can help practitioners overcome the barriers to TB
diagnosis, treatment and screening described in the case report.
1. Screening and management of
tuberculosis in immigrants 
The case report from Bishara et al.1 of active TB occurring in four
members of a family recently migrated from Ethiopia to Israel
provides an excellent basis for considering how primary care can
contribute to early diagnosis and treatment of TB.  The authors
provide a thorough assessment of the barriers that led to delay in
diagnosis in all four family members, and a clear description of the
challenges of appropriate management. One aspect not addressed,
and which potentially could have had a key influence on the
evolution of the disease in all four cases, is the impact of screening
for TB – and other infectious diseases – in primary care. 
Health of migrants
Migrants make up an increasing proportion of European
populations.2 Migrants often have complex health care needs, being
at increased risk of communicable and non-communicable disease,
as well as social and psychological problems, sometimes arising from
trauma experienced in their countries of origin. Good health care for
migrants is therefore an important area, but one which is frequently
marginalised through political controversy in a time of scarce health
care resources.
The family in the case report have recently migrated from
Ethiopia, a country afflicted by rates of both TB and Human
Immunodeficiency Virus (HIV) that are amongst the highest in the
world (TB incidence: 247/100,000 population;3 HIV prevalence
1.4% in the adult population4). The family must therefore be
considered at increased risk of these infections. 
Most cases of active TB in the UK arise after migration from
reactivation of latent disease, rather than being acquired by new
cross infection.5 Thus, screening for active disease in the country of
origin or at the port of entry for active disease is relatively ineffective.
What triggers reactivation of disease after migration is unclear, but
potentially reflects influences including the development of vitamin
D deficiency or ill-defined effects of stress on the immune system.
Guidelines on screening for TB and HIV
UK guidelines recommend screening migrants for both TB and HIV
in primary care.6-8
For new entrants from countries with a high incidence of TB, the
UK National Institute for Health and Care Excellence (NICE)
recommends:6
• For children under 5 years, offer a Mantoux (tuberculin) skin test.
If strongly positive, refer to consider treating latent TB. 
• For children aged 5–15 years, offer a Mantoux test. If positive,
follow with an Interferon Gamma Release Assay (IGRA). 
• For people aged 16–35 years, offer either an IGRA alone or a
dual strategy (Mantoux test followed by IGRA). 
• For people over 35 years, consider the individual risks and
benefits of likely subsequent treatment before offering testing.
For HIV, NICE recommends that:
‘All health professionals should routinely offer and recommend an
HIV test to men and women known to be from a country of high
HIV prevalence.’7
How effective is screening and what evidence
supports these recommendations?
a) Screening for TB in primary care is effective and
acceptable
In a cluster randomised trial of 50 general practices, set in inner
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London, practices trained to screen people registering in primary
care for TB significantly increased the proportion of cases of TB
diagnosed in primary care.9 Screening was acceptable to migrants10
and was probably cost-effective.11 Screening consisted of a short set
of questions on symptoms of active TB, followed by a tuberculin skin
test and if indicated, a chest X-ray and sputum samples for
microscopy and culture for acid fast bacilli. Since 2007, general
practices in Hackney, east London have routinely offered TB
screening to new entrants when they register in primary care. During
this period incidence of TB has halved in the borough. 
b) Interferon gamma release assays are a useful
screening test for TB in primary care
Drawbacks of the traditional tuberculin skin test for TB include poor
sensitivity and specificity (especially in people immunised with BCG),
and the need for the patient to return to have their test read.
Interferon gamma release assays (IGRA) overcome both of these
problems. They work on the principle that white blood cells (T-
lymphocytes) of a person infected with TB will release interferon
gamma when stimulated by antigens unique to Mycobacterium
tuberculosis (CFP-10 and ESAT-6). Neither the BCG bacillus nor non-
mycobacterial TB have these antigens. The place of IGRA testing is
evolving, but studies of serology testing of migrants in primary care
show that it is probably a cost-effective way of screening for latent
TB infection.12 A further advantage is that the blood drawn can also
be tested for other infections, such as HIV and hepatitis. Modelling
suggests that screening with IGRA could replace screening at port of
entry with chest radiography.12
c) Screening for HIV in primary care is effective and
acceptable
Results of a recent cluster randomised trial of 40 practices in east
London show that training practices to screen new registrants for
HIV using a point-of-care rapid HIV test leads to increased and earlier
detection of HIV.13 A majority of the new cases of HIV found in this
study were in black Africans, highlighting the ability of a primary
care-based approach to reach an important at-risk group. This study
is the first randomised study to test the impact of screening for HIV
and lends support for NICE recommendations on HIV testing.
More importantly, these studies show that primary care can
play a critical role in screening migrants for infectious disease. On
the basis of these studies, primary care in some east London
boroughs is adopting a model of screening by serology or rapid
point-of-care testing for multiple infectious diseases in migrants
registering in primary care. Screening is supported by locally
agreed incentive programmes. 
Implications for this case report
Potentially therefore, the family featured in the case report by
Bishara et al. could have been screened for TB, HIV and other
infectious diseases such as hepatitis when they registered in primary
care. It is possible that they could have been screened at an
asymptomatic stage when the entire family may have had latent,
rather than active TB. Positive results of screening would have
triggered referral for further assessment by the local specialist TB
team. It is likely they would have been offered chemoprophylaxis to
prevent reactivation of TB. Early identification of latent TB infection
in these family members could have prevented reactivation to active
disease and – in the case of those members with pulmonary TB (the
mother and children) – potential further transmission to others.
Clearly these benefits would only be possible if migrants are able,
and indeed encouraged, to register in primary care. The public
health implications of effective screening of migrants both for
migrants themselves and wider society are obvious. Any measures
that restrict access to health care for migrants are to be resisted.
2. Diagnosis and treatment of tuberculosis
in low-income countries 
According to the 2012 World Health Organization report, TB is now
a major health problem worldwide with a global incidence of 8.6
million and mortality of 1.3 million.14 With most cases occurring in
Asia (58%) and Africa (27%), TB seems to be a disease of the under-
privileged, resource-limited developing nations. Factors explicitly
linked with poverty such as malnutrition, overcrowding, poor
healthcare infrastructure and a higher number of people living with
HIV (PLHIV) are all responsible for the increased burden of TB in the
developing world.15,16 
Diagnosis of TB is a challenge due to the long latent period,
outreach to almost every organ of the body, and varied
presentations. Timely detection of pulmonary TB cases, which
constitute about 85% of all TB cases, is especially important since
they contribute to the chain of transmission in the community.14 In a
high-burden country, the index of suspicion should be high but
rational. Any patient with signs and symptoms suggestive of TB
should be called as ‘Presumptive TB’ (earlier labeled as TB suspect)
and should be evaluated17 (see Figure 1).
Amongst the four diagnostic arms of TB – clinical,
microbiological, pathological and radiological – microbiological
diagnosis is the most specific and reliable and all efforts must be
made to establish a microbiological diagnosis. Serodiagnosis may be
used as a screening tool in developed countries, but in a resource-
limited setting these inaccurate and imprecise tests merely add to
the cost of the country’s TB control programmes and hence are not
recommended by WHO18,19 (see Figure 2). 
Important points to note about the diagnostic
algorithm
• When sputum is not easily obtainable, use induced sputum or
gastric aspirates (especially in children) or bronchoscopic lavage
where available.23,24 
• Sputum processing methods involving bleach digestion,
centrifugation or gravity sedimentation may be employed.21,25-27
Figure 1.  Presumptive TB which needs evaluation
• Patients with unexplained productive cough for >2 weeks with or
without other symptoms5 
• Patients with systemic symptoms like fever, night sweats, weight loss
• Contact of a case
• PLHIV
• Lymphadenopathy*
• Pleural effusion*
* Especially in PLHIV
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• LED microscopy, which is more sensitive than conventional ZN
microscopy and has qualitative, operational and cost advantages
over both conventional fluorescence and ZN microscopy, may be
utilised where feasible.21,26,28
• In cases of pauci-bacillary TB, children and PLHIV, solid or liquid
cultures or molecular tests may be done. Rapid molecular tests
like GenoType® MTBDRplus and Xpert® MTB/RIF have now been
endorsed by WHO based on emerging evidence.
• Chest X-ray (CXR) is a sensitive but nonspecific test to detect TB
with 10-15% under-reading and about 40% over-reading.25
However, when the pre-test probability is high and in PLHIV, CXR
may be ordered up-front if the initial smears are negative.29 Few
cases may require a CT scan for confirmation.
Extra-pulmonary tuberculosis When extra-pulmonary TB is
suspected, appropriate specimen(s) from the affected site should be
obtained and examined microbiologically, followed by microscopy or
culture. Most such cases are pauci-bacillary, hence imaging modalities,
cytology and histopathology are often required. Adenosine deaminase
levels in body fluids are a useful adjunct in these cases but are not very
specific. All these cases must be evaluated for concurrent pulmonary
TB, especially in the presence of cough.22,25
Categorisation of patients Based on the above, patients are
categorised as a “bacteriologically-confirmed” or as a “clinically
diagnosed” case depending on whether microbiological
confirmation with microscopy, culture or molecular methods is
available or not.4 Meticulous follow-up and reconsideration of
diagnosis should be done for the latter case should such evidence
appear in due course. Cases are also classified depending on the
anatomical site of disease, history of previous treatment (relapse,
failure, or lost to follow-up), drug resistance (if known) and HIV
status.
Treatment
New cases All new cases are recommended to take 6 months
treatment:
• Intensive phase: 2 months of isoniazid(H), rifampicin(R),
pyrazinamide(Z) and ethambutol(E)
• Continuation phase: 4 months of HR
In populations where prevalent isoniazid resistance is high (based on
surveillance studies), ethambutol may be added to HR in the
continuation phase.
Drug dosages should be based on the patient’s weight as
advocated by WHO.22
Retreatment cases Patients who have received at least one month’s
treatment in the past and who present again with active disease –
either because of treatment failure, relapse or they were lost to
follow-up – represent an important group since around 20% of
Figure 2.  Diagnostic algorithm for pulmonary tuberculosis.20 As used in India and endorsed by Central TB Division,
Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India
Cough for 2 weeks or more
At least 2 (preferably 3) sputum smears
for Ziehl Neelsen stain (1 spot and one morning)
One or both samples positive
(showing Acid Fast Bacilli)21,22
Both samples negative
Give broad spectrum antibiotics like: Amoxycillin, co-trimoxazole or Doxycycline
(not fluoroquinolones, which have antitubercular activity) for 2 weeks
Cough persists
Repeat two sputum examinations
1 or 2 positive Both negative
X-Ray Chest
Sputum positive pulmonary TB start Anti-TB treatment
Suggestive of TB Negative for TB
Non-PTB
Sputum negative pulmonary TB
start Anti-TB treatment
Sensitivity
(20-80%)21
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them may have Multi Drug Resistant TB (MDR TB)14  - see Figure 3.
It is most important for all National Tuberculosis Programmes
(NTPs) that countries have their own nation-specific guidelines to
define MDR suspects, and management of retreatment cases should
be based on surveillance data, resource availability, laboratory
infrastructure and other population-specific issues.
“Failure” cases are more likely to have MDR than the other two
retreatment categories and some countries may adopt a “mixed”
approach.22 
Frequency of treatment There is increasing evidence to advocate
daily dosing schedules to reduce the risk of treatment failure, relapse
and acquired drug resistance.30,31 WHO recommends that the
optimal dosing frequency is daily. However, for convenience of
implementation, thrice-weekly treatment is acceptable during the
continuation phase only if every dose is directly observed (termed
‘Directly Observed Treatment’ or DOTS). Directly observed, thrice-
weekly therapy throughout treatment is acceptable if HIV infection
is ruled out.22 
Follow-up Repeat sputum examination at the end of the intensive
phase and at the end of treatment is required. Repeat sputum
evaluation during the middle of the continuation phase is no longer
recommended.22,32 Any sputum positivity during follow-up makes the
patient an MDR suspect and NTPs may advocate culture/DST.
Readers are referred to comprehensive guidelines available for the
management of MDR TB.33,34 
Conclusion
TB has now re-emerged as a major health hazard, and resource-
limited countries need to build up robust National Tuberculosis
Programmes (NTPs) based on epidemiological and clinical evidence
to overcome the socio-cultural and economic limitations of the
country. Apart from trying to upgrade the diagnostic and
therapeutic facilities of the country, the NTPs should also aim at
educating health care providers at all levels, increasing public
awareness, promoting lifestyle improvement and cough etiquettes in
the community. Progressively moving towards universal access to
healthcare, adherence to guidelines, and changing attitudes, it is a
realistic optimism that the next generation may live in a TB-free
world.
3. Why the anthropological approach is
valuable to family doctors treating patients
with tuberculosis from different cultures 
The article by Bishara et al.1 in this issue is instructive for many
reasons. TB remains an important public health problem in many
parts of the world, including Portugal. There were 2500 new cases
reported in Portugal in 2009, giving an annual incidence of 24 per
100,000.35 Maintaining a high index of suspicion and remaining
vigilant in finding close contacts at risk for infection is a constant
challenge. TB in pregnancy is also a diagnostic and therapeutic
challenge that requires clinical expertise.36 But the added value of
this case report lies in the cross-cultural lessons that it can teach us.  
The arrival of Jewish immigrants from Ethiopia to Israel in two
large waves in the 1980s and 1990s presented a significant
challenge to Israeli society and the healthcare system.37 Infectious
diseases including malaria, TB and intestinal parasites presented
challenges to clinicians who were unfamiliar with these conditions.38
Figure 3.  Algorithm for management of retreatment cases. Adapted from: World Health Organization. Treatment of
tuberculosis guidelines. 4th Edition, 2010, Pg 38-39
*Guidance on designing a country’s standard MDR regimen is provided in Chapter 7, Reference 22 #S-Streptomycin
Retreatment case
Sputum culture and Drug Sensitivty Test (DST)
Countries where conventional DST available and results are awaited
(About 10 days for liquid media and 28 to 42 days for solid media)
Populations with high prevalence of MDR Populations with low prevalence of MDR
Empirical MDR regimen based  on
the country’s drug resistance 
surveillance data* should be administered
Retreatment with first line drugs
2HRZES#/1HRZE/SHRE
DST Results obtained
Treat as per DST results
(Modify empirical as per DST)
Countries where
rapid molecular based
DST available
(Results in 2 days)
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More important, patients speaking a different language coming
from an African agrarian society and arriving in a post-industrial
Western society with very different values from those of the host
culture experienced a profound sense of culture shock. This resulted
in depression, suicides and other forms of social disruption.39 The
healthcare system required different tools to cope with this.
Help was available in the form of medical anthropology. The
work of Arthur Kleinman,40 Cecil Helman41 and others has direct
application to the work of family doctors. When a patient says,
“Feed a cold and starve a fever,” they are referring to widely-held
health beliefs that can have significant effects on their health
behaviours. If they prefer chicken soup to antibiotics for respiratory
infections, this can also affect outcomes. Culturally-bound health
beliefs and practices can affect consulting rates, attendance at
screening programs and treatment compliance, including
completion of TB treatment.42
It has been argued that all medical encounters are cross-cultural
encounters. The ability to ask the right questions respectfully, to
listen attentively, to learn the cultural lessons presented, and to apply
these lessons effectively in diagnosis and treatment, are the legacy of
medical anthropology. This, in fact, is a definition of patient-centred
care.43 Linguistic translation is not enough. Cultural interpretation is
necessary in cross-cultural medicine as well. Simple questions such
as, “What do you think is causing your problem?”, “What do you
call this in your language?”, “What do you require to treat it?”,
“What will happen if you treat it?”, “What will happen if you
don’t?”, and “How long will this last?”, are all useful in building
bridges of cultural understanding about disease. All doctors learning
about their patients’ health belief models can apply these questions.
Fortunately, expert resources were available and were used in the
successful absorption of Ethiopian immigrants to Israel. Medical
anthropologists who had studied the medical culture of Ethiopia
were indispensible at the beginning of this adventure.44 The language
and concepts of health and disease, the use of traditional medicines
and traditional healers, and the system of values related to health all
needed to be explained to health professionals in the host culture.
Translation was provided initially, especially for older patients who
spoke little or no Hebrew. Later, because of their language
acquisition skills, children became interpreters for the elders, even
though this was often inappropriate in medical encounters.
As expertise and trust grew, and social barriers broke down,
other techniques were employed. Long interviews and focus group
methods were employed to help decipher the codes of health beliefs
and behaviours.45 Parents revealed how common symptoms such as
fever or anorexia were viewed as symptoms of malaria or other
diseases unfamiliar to their new doctors. Other symptoms such as
weight loss and difficulty feeding in the newborn child might call for
traditional procedures like excision of the uvula, which were also
foreign. A belief in the power of injections to heal compared to the
relative inefficiency of tablets might lead to difficulties in adherence
to long-term regimens such as TB treatment. Belief in the
therapeutic power of blood-letting on the other hand might lead to
surprising compliance with requests to appear for laboratory tests
requiring venipuncture.46
The success of culture-sensitive medicine can be seen in the
diagnosis, treatment and prevention of TB in the Ethiopian
community in Israel. Although cases still appear, as this case report
demonstrates,1 and constant vigilance is required among health
workers caring for members of this community, this can be
considered a success story.47
Other developments that are worth noting are the training of
community health workers from among the immigrants themselves.
The innovative Refuah Shlema program has resulted in the
successful integration of motivated, idealistic members of the
community into the health care team. Their credibility, respect and
effectiveness among their fellow immigrants and the next
generation of native born Israelis of Ethiopian origin is a remarkable
achievement and an example worth copying.48 The next challenge
the society faces, as infections like TB are overcome, is the growing
problem of obesity and diabetes in this community. While almost
unheard of in Ethiopia, this is becoming a public health problem.
Acculturation has health risks as well as benefits, and unique
culturally-sensitive solutions are needed to face this issue too.49
Rapid international travel and freely mobile populations draw
these cross-cultural medical issues into sharp focus. Air travel was
implicated in the spread of the recent SARS epidemic. Cultural issues
require attention in the management of infectious and non-infectious
diseases and will continue to occupy our attention in medicine.
Conclusion
Tuberculosis remains a significant public health problem in both
high- and low-prevalence countries. Sharing of knowledge and
experience from many settings and disciplines, as demonstrated in
the case report by Bishara et al.,1 and in this Perspective article, will
be necessary to achieve the goal of a TB-free world.
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